secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oscar Health, Inc. (OSCR)
CIK:        0001568651
Form:       8-K
Filed at:   2026-09-16T10:02:42+00:00
Accession:  0001568651-26-000074
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Oscar Health raises FY 2026 EBITDA guidance by $100M, improves MLR outlook by 50 bps
--------------------------------------------------------------------------------

- FY 2026 earnings from operations guidance raised to $600M-$800M from $500M-$700M, up $100M.
- FY 2026 medical loss ratio narrowed to 81.0%-82.0% from 81.5%-82.5%, a 50 bps improvement.
- Total revenue reaffirmed at $18.7B-$19.0B; SG&A expense ratio reaffirmed at 15.6%-16.1%.
- Guidance issued at Sept 16, 2026 Investor Day; webcast archived on IR site for 90 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1568651/000156865126000074/0001568651-26-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1568651/000156865126000074/oscr-20260916.htm
  HTML page:      https://secwatch.observer/filing/0001568651-26-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer